Single-use System– tag –
-
Bio-Link Report: Single-Use Systems Transform Vaccine Sterile Manufacturing into ‘Flexible Smart Manufacturing’, Achieving Enhanced Efficiency and Cost Reduction with 2000L+ Bioreactors
Bio-Link Unknown Overview A Bio-Link report states that single-use systems are transforming vaccine sterile manufacturing from a 'steel jungle' into 'flexible smart manufacturing.' These systems enable cost reduction, accelerated technol... -
Scire Science Launches SBIO-420 Benchtop Bioreactor to Strengthen India’s Biomanufacturing Ecosystem with Precision and Enhanced Yields
Scire Science India Overview Scire Science unveiled the SBIO-420 Benchtop Magnetic Stirring Glass Bioreactor, aimed at strengthening India's biotechnology ecosystem. Designed for precision and ease of use, it supports advanced microbial ... -
Biopharmaceutical CDMO Capacity Crunch Persists, Driving Rapid Expansion in Cell and Gene Therapy Production
Contract Pharma USA Overview The biopharmaceutical industry continues to face a CDMO capacity crunch, prompting contract development and manufacturing organizations to heavily invest in expanding production capabilities, particularly for... -
Chime Biologics Unveils AI-Driven Biomanufacturing Future with New Wuhan GMP-2 Facility and 100+ Bioreactor Megafactory Vision
BioPharma APAC China Overview Chime Biologics has significantly bolstered its biopharmaceutical manufacturing capabilities with the opening of its GMP-2 facility in Wuhan, China, equipped with eight Cytiva 2,000-liter single-use Xcellere... -
Gene Therapy Manufacturing: Viral Vector CDMOs Confront Oversupply Amidst Rapid Expansion
IntuitionLabs USA Overview A recent industry report offers a comparative analysis of the AAV and lentiviral vector CDMO market, revealing trends of consolidation and emerging capacity oversupply. It highlights key players like FUJIFILM D... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Sartorius Unveils AI-Enabled Ambr 250 HT and Pionic Platform, Sustains Strong H1 2026 Business Growth and Profitability
boerse.de Germany Overview Sartorius Stedim Biotech has expanded its solution portfolio with the launch of the AI-enabled Ambr 250 HT Cell Therapies Vessel and the Pionic platform for intensified continuous bioprocessing. These innovatio... -
PBS Biotech Joins Organoid COMMONS with Vertical-Wheel® Bioreactor to Accelerate Industrialization and Scalability of Human Organoid Models
PR Newswire (PBS Biotech) USA Overview PBS Biotech has joined Organoid COMMONS to accelerate the industrialization and scalability of human-relevant organoid models. The company contributes its unique Vertical-Wheel® bioreactor platform ... -
FUJIFILM Biosciences Unveils Oceo Rover, the First On-Demand Automated Solution for Powdered Media and Buffer Hydration, Resolving Bioprocess Bottlenecks
Bioprocess Online (FUJIFILM Biosciences) Japan Overview FUJIFILM Biosciences has launched the Oceo Rover, the first on-demand automated solution for powdered media and buffer hydration. This innovative system integrates hydration and ste... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o...
